A quantitative assessment of alkaptonuria: Testing the reliability of two disease severity scoring systems

Journal of Inherited Metabolic Disease

Volumn 34, Issue 6, 2011, Pages 1153-1162

  Cox, Trevor F ^a   Ranganath, Lakshminarayan ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALKAPTONURIA; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EAR DISEASE; EVIDENCE BASED MEDICINE; EYE DISEASE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; OCHRONOSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALKAPTONURIA; CAUSALITY; COHORT STUDIES; COMORBIDITY; CYCLOHEXANONES; FEMALE; HOMOGENTISATE 1,2-DIOXYGENASE; HOMOGENTISIC ACID; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITROBENZOATES; OCHRONOSIS; PAIN; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING;

EID: 82955232922     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9367-8     Document Type: Article

References (15)

1. M Beck 2006 The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease Acta Pædiatrica. Suppl 451 43 46 10.1080/08035320600618825 (Pubitemid 43739094)
2. JM Bland DG Altman 1997 Statistical Notes: Chronbach's alpha BMJ 314 572 9055718 10.1136/bmj.314.7080.572 1:STN:280:DyaK2s3gvVOktA%3D%3D
3. Committee for Medicinal Products for Human Use (CHMP) (2006) Guidelines on clinical trials in small populations (CHMP/EWP/83561/2005). European Medicines Agency, London
4. Cox TF, Cox MAA (2001) Multidimensional Scaling. Chapman & Hall, Boca Raton
5. RB D'Agostino 2009 The delayed-start study design N Engl J Med 361 13 1304 1306 19776413 10.1056/NEJMsm0904209
6. JM Fernandez-Canon B Granadino D Beltran-Valero de Bernabe, et al. 1996 The molecular basis of alkaptonuria Nat Genet 14 19 24 8782815 10.1038/ng0996-19 1:CAS:528:DyaK28Xls1SqtL4%3D (Pubitemid 26301542)
7. Gerss JWO, Köpcke W (2010) Clinical trials and rare diseases. In: Paz M, Groft SC (eds) Rare Diseases Epidemiology (Advances in Experimental Medicine and Biology 686). Springer, Dordrecht, pp 173-190
8. RJ Goodfellow J Schwartz F Leya 2005 Black aorta: a rare finding at aortic valve replacement J Invasive Cardiol 17 165 167 15867448 (Pubitemid 41724706)
9. JC Gower 1971 A general coefficient of similarity and some of its properties Biometrics 27 857 874 10.2307/2528823
10. TR Helliwell JA Gallagher L Ranganath 2008 Alkaptonuria - a review of surgical and autopsy pathology Histopathol 53 503 512 1:STN:280: DC%2BD1cjhsFChtg%3D%3D
11. SW Lagakos 2003 Clinical trials and rare diseases N Engl J Med 348 24 2455 2456 12802033 10.1056/NEJMe030024 (Pubitemid 36682826)
12. WM O'Brien BN La Du JJ Bunim 1963 Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584-1962) Am J Med 34 813 838 10.1016/0002-9343(63)90089-5
13. C Phornphutkul WJ Introne MB Perry, et al. 2002 Natural history of alkaptonuria N Engl J Med 347 2111 2121 12501223 10.1056/NEJMoa021736 1:CAS:528:DC%2BD3sXhslGn (Pubitemid 36015123)
14. Ranganath LR, Cox TF (2011) Natural history of alkaptonuria revisited: analyses based on scoring systems. JIMD (in press)
15. A Wilke D Steverding 2009 Ochronosis as an unusual cause of valvular defect: a case report J Med Case Reports 3 9302 20062791 10.1186/1752-1947-3- 9302